A new study from Cedars-Sinai Cancer reveals a potential way to overcome tumor resistance to a common chemotherapy drug ...
Cisplatin was purchased from Sigma-Aldrich (St ... and Δ8-THC (Chemical structures shown in Figure 1A) were evaluated in a human ovarian cancer cell line (Caov-3 cells). At a lower concentration (10 ...
Cisplatin and etoposide are already used ... "While current chemotherapy regimes are effective for some women with ovarian cancer, many relapse later and overall cure rates are improving only ...
Epithelial ovarian cancer is the fourth biggest cause of cancer-related death in women. Over recent decades, improvements have been made in treatment outcome in terms of response rate and survival.
Shortages of platinum-based chemotherapy drugs raise concerns as they may lead to increased cancer mortality due to delayed ...
Ovarian cancer is when abnormal cells in the ovary, fallopian tube or peritoneum begin to grow and divide in an uncontrolled way. They eventually form a growth (tumour). If not caught early, cancer ...
This stands for the chemotherapy drugs bleomycin, etoposide and cisplatin. This combination is very good at preventing germ cell cancers from coming back. Rarely, you might have radiotherapy to try ...
But what if they could prevent the spread of cancer altogether? Well, that’s precisely what OvarianVax, the world’s first ovarian cancer prevention vaccine, strives to do. Researchers at the ...
Medicare covers screenings, diagnostic testing, FDA-approved treatment, and continued monitoring for cancer, including ovarian cancer. Medicare does not cover experimental cancer treatments.
A prospective, longitudinal study sought to determine the effects of nutrition status, daily habits, and sleep pattern on length of stay in patients with ovarian cancer undergoing chemotherapy.